期刊文献+

双边可调式外固定支架结合有限内固定治疗Eichenholtz 3期中后足Charcot关节病 被引量:5

下载PDF
导出
摘要 目的:探索应用双边可调式外固定支架结合有限内固定治疗Eichenholtz 3期中后足Charcot关节病。方法:总结2008年3月至2011年4月年14例Eichenholtz 3期中后足Charcot关节病。采用双边可调式外固定支架牵张复位重建中后足骨关节结构,行关节融合同时调整足内外侧柱长度,对比手术前后足部形态及功能。结果:随访14例患者至完全负重行走后27周,关节完全骨性融合时间平均19周,完全负重行走时间平均21周,最终均达到关节骨性融合,形成稳定的跖行足。对比手术前后内柱高度、侧位距骨第一跖骨角、距舟覆盖角、距跟角都有明确改善。AOFAS评分术前平均46分,术后平均78分。结论:采用双边可调式外固定支架结合有限内固定治疗Eichenholtz 3期中后足Charcot关节病,能最大限度重建中后足骨性结构,使脱位畸变关节达到稳定骨性融合,矫正畸形,调整足部应力分布,有效改善患者足部症状。
出处 《实用医学杂志》 CAS 北大核心 2013年第20期3387-3389,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献9

  • 1Tomas M B, Patel M, Marwin S E, et al. The diabetic foot [J]. Br J Radiol, 2000,73, (868) :443-450.
  • 2Rajbhandari S M, JenKins R C, Davies C, et al. Charcot neuroarthropathy in diabetes mellitus [J]. Diabetologia, 2002, 45, (8) : 1085-1096.
  • 3Brodsky J W, Rouse A M. Exostectomy for symptomatic bony prominences in diabetic charcot feet [J]. Clin Orthop Relat Res, 1993, (296) :21-26.
  • 4Eichenholtz S N. Charcot joints [M]. Charles C. Thomas, 1966.
  • 5Bradley M, Lamm H, Gottlieb D, et al. A Two-Stage Percutaneous Approach to Charcot Diabetic Foot Reconstruction [J]. Journal of Foot and Ankle Surgery, 2010,49(6):517-522.
  • 6Capobianco C M, Stapleton J J, Zgonis T. The role of an extended medial column arthrodesis for Charcot midfoot neuroarthropathy [J]. Diabetic Foot & Ankle, 2010, 1:5282.
  • 7Sammarco V J, Sammarco G J, Walker E W Jr, et al. Midtarsal arthrodesis in the treatment of Charcot midfoot arthropathy [J]. J Bone Joint Surg Am, 2009,92( 1):1-19.
  • 8Mittlmeier T, Klaue K, Haar P, et al. Should one consider primary surgical reconstruction in charcot arthropathy of the feet [J]. Clin Orthop Relat Res, 2010,468(4):1002-1011.
  • 9谭晓毅,杜远立,蔡瑾,武斌,李云.创伤后距骨坏死的进程及治疗[J].实用医学杂志,2012,28(3):453-454. 被引量:3

二级参考文献5

共引文献2

同被引文献36

  • 1Sanders LJ, Edmonds ME, Jeffcoate WJ. Who was first to diagnose and report neuropathic arthropathy of the foot and ankle: Jean-Martin Charcot or Herbert William Page? [J]. Diabetologia, 2013, 56(9) : 1873-1877.
  • 2Botek G, Anderson MA, Taylor R. Chareot neuroarthropatby an often overlooked complication of diabetes[J]. Cleve Clin J Med, 2010, 77(9) 593-599.
  • 3Memarpour R, Tashtoush B, Issac L, et al. Syringomyelia with Chiari I malformation presenting as hip charcot arthropathy : a case report and literature review[J]. Case Rep Neurol Med, 2015, 2015:487931.
  • 4Stuck RM, Sohn MW, Budiman-Mak E, et al. Charcot arthropathy risk elevation in the obese diabetic population [J]. AmJ Med, 2008, 121(11):1008-1014.
  • 5Rogers LC, Frykberg RG, Armstrong DG, et al. The Charcot foot in diabetes[J]. Diabetes Care, 2011, 34 (9) : 2123-2129.
  • 6Baumhauer JF, O' Keefe RJ, Schon LC, et al. Cytokine -induced osteoclastic bone resorption in charcot arthropathy: an immunohistoehemical study[J]. Foot Ankle Int, 2006, 27 (10) :797 800.
  • 7Varma AK. Chareot neuroarthropathy of the foot and ankle: a review[J]. J Foot Ankle Surg, 2013, 52(6):740-749.
  • 8Grahovac G, Vilendecic M, Srdoc D. Chareot shoulder caused by Chiari type I malformation with syringomyelia with six-year follow-up[J]. Wien Kiln Wochenschr, 2011, 123(15-16) : 512-514.
  • 9van Baal J, Hubbard R, Game F, et al. Mortality associated with acute Charcot foot and neuropathic foot ulceration[J]. Diabetes Care, 2010, 33(5) : 1086-1089.
  • 10Rosenbaum AJ, DiPreta JA. Classifications in brief: Eiehenholtz classification of Chareot arthropathy[J]. Clin Orthop Relat Res, 2015, 473(3) :1168-1171.

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部